Functional heterogeneity of calcium release by inositol trisphosphate in single Purkinje neurones, cultured cerebellar astrocytes, and peripheral tissues.
Purkinje neurones of the cerebellar cortex are rich in receptors for the Ca-mobilizing second messenger inositol trisphosphate (InsP3) in association with intracellular Ca stores. Cytosolic Ca ions are important in regulating neuronal excitability but it has proved difficult to demonstrate InsP3-evoked release of Ca in mammalian central neurones directly. Intracellular release of InsP3 by flash photolysis of caged InsP3, combined with whole-cell patch clamp and microspectrofluorimetry of Ca indicators, allows comparison of InsP3-evoked Ca release in single Purkinje cells in cerebellar slices with the same process in cultured astrocytes and peripheral tissues. In astrocytes, hepatocytes, exocrine cells, and vascular endothelium, minimal Ca release from stores requires photorelease of InsP3 at concentrations of 0.2-0.5 microM, and maximal efflux as judged by the rate of increase of Ca concentration is seen with 5-10 microM InsP3. In contrast in Purkinje cells, InsP3 concentrations of > or = 9 microM were required to produce minimal Ca release from stores under the same conditions, and Ca efflux increased with InsP3 concentrations up to 70-80 microM. Furthermore, the rate of increase and size of the Ca concentration in Purkinje cells are 10- to 30-fold greater than in astrocytes and peripheral tissues. The InsP3 sensitivity was not affected by changing exogenous cytosolic Ca buffering, suggesting that endogenous Ca binding cannot account for the difference. The results show a functional difference in InsP3-evoked Ca release between Purkinje cells and peripheral tissues.
National Institute for Medical Research, Mill Hill, London, United Kingdom.
K
K
Khodakhah
D
D
Ogden
D000814:Aniline Compounds; D000818:Animals; D001253:Astrocytes / Q000187:drug effects / Q000502:physiology*; D002118:Calcium / Q000378:metabolism*; D002478:Cells, Cultured; D002531:Cerebellum / Q000187:drug effects / Q000502:physiology*; D005452:Fluoresceins; D005456:Fluorescent Dyes; D015544:Inositol 1,4,5-Trisphosphate / Q000494:pharmacology*; D008564:Membrane Potentials / Q000187:drug effects; D009474:Neurons / Q000187:drug effects / Q000502:physiology*; D010782:Photolysis; D011689:Purkinje Cells / Q000187:drug effects / Q000502:physiology*; D051381:Rats; D013050:Spectrometry, Fluorescence; D014466:Ultraviolet Rays; D014966:Xanthenes
D000814:Aniline Compounds; D005452:Fluoresceins; D005456:Fluorescent Dyes; D014966:Xanthenes; C059715:Fluo-3; C043829:2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein; D015544:Inositol 1,4,5-Trisphosphate; D002118:Calcium